Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Current Hematologic Malignancy Reports|June 21, 2019
Mantle Cell Lymphoma: Which Patients Should We Transplant?James N Gerson, Stefan K Barta
Clinical Advances in Hematology & Oncology : H&O|June 1, 2018
Managing adverse effects of immunotherapyJames N Gerson, Chethan Ramamurthy, Hossein Borghaei
Expert Opinion on Investigational Drugs|April 8, 2017
Perspectives of HER2-targeting in gastric and esophageal cancerJames N Gerson, Sam Skariah, Crystal S Denlinger, et al.
Leukemia & Lymphoma|June 7, 2026
Chimeric antigen receptor T-cell therapy induces complete remission in a patient with concurrent CLL with CNS involvement and multiple sclerosisDermot J Murphy, Siba El Hussein, Angela Applebee, et al.
Pancreas|October 18, 2017
Carcinoid Syndrome Complicating a Pancreatic Neuroendocrine Tumor: A Case ReportJames N Gerson, Ronald M Witteles, Daniel T Chang, et al.
Digestive Diseases and Sciences|May 29, 2021
Endoscopy Is Not Associated with Infectious Adverse Events After Hematopoietic Cell Transplantation: A Retrospective Cohort StudyAbraham Segura, Rahul S Dalal, Meghana Golla, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 26, 2019
Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma With Venetoclax: A Single-Center Evaluation of Off-Label UseMitchell E Hughes, Daniel J Landsburg, Daniel J Rubin, et al.
Oncotarget|November 28, 2022
Mutation analysis performed on tumor biopsies from patients with newly-diagnosed germinal center aggressive B cell lymphomasDaniel J Landsburg, Jennifer J D Morrissette, Stephen J Schuster, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 22, 2020
Ibrutinib-associated Arthralgias/Myalgias in Patients With Chronic Lymphocytic Leukemia: Incidence and Impact on Clinical OutcomesJoanna M Rhodes, Vincent A LoRe, Anthony R Mato, et al.
Transplantation and Cellular Therapy|May 21, 2023
Survival Outcomes for Patients with Relapsed/ Refractory Aggressive B Cell Lymphomas Following Receipt of High-Dose Chemotherapy/Autologous Stem Transplantation and/or Chimeric Antigen Receptor-Modified T CellsDaniel J Landsburg, Sunita D Nasta, Jakub Svoboda, et al.
Pageof 4